Skip to content
CLColgate-Palmolive Company

What Is CL Fair Value?

Colgate-Palmolive Company (CL) fair value estimate using multiple valuation models, updated daily.

As of September 15, 2026, Colgate-Palmolive Company (CL) has a composite fair value estimate of $74.05 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $87.00, suggesting the stock is fair value by 14.9%.

Data as of September 15, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$74.05

vs. current price of $87.00(-14.9%)

Undervalued$74.05Overvalued
$87.00

How Is CL Fair Value Calculated?

Four independent models estimate what CL is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CL Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$130.67

+50.2%

Undervalued

Inputs used

FCF: 3.5BGrowth: 5.5%Discount: 6%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$61.91

-28.8%

Overvalued

Inputs used

Dividend: $2.12/yrReq. Return: 6%Growth: 2.8%

CL Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$5.08

-94.2%

Overvalued

Inputs used

EPS: $3.88Book Value: $0.30

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$38.75

-55.5%

Overvalued

Inputs used

EPS: $3.88Growth: 5.5%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$130.67Undervalued

Current price $87.00 is 50.2% below this estimate

CheapFair ValueExpensive
5.5%
0.0%30.0%
6.0%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$3.65B$3.44B
Year 2$3.85B$3.42B
Year 3$4.06B$3.41B
Year 4$4.29B$3.39B
Year 5$4.52B$3.37B
Year 6$4.77B$3.36B
Year 7$5.04B$3.34B
Year 8$5.31B$3.32B
Year 9$5.61B$3.31B
Year 10$5.92B$3.29B
Terminal Value$171.30B$95.30B

What Are CL's Key Financial Metrics?

Earnings & Growth

Current Price

$87.00

EPS (TTM)

$2.54

Forward P/E

21.2

Profit Margin

9.7%

Cash & Balance Sheet

Free Cash Flow

3.5B

EBITDA

5B

Book Value

$0.30

Total Debt

7.9B

What Do Analysts Say About CL?

Low

$87.00

Average

$98.95

High

$110.00

Upside

+13.7%

Current $87.00Avg Target $98.95Buy20 analysts

CL Fair Value FAQ

What is the fair value of CL?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CL's estimated fair value is $74.05. The stock is currently trading at $87.00, which makes it fair value by our analysis.

How is CL's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CL overvalued or undervalued?

Based on our analysis, CL is fair value. The current price of $87.00 is 14.9% above our estimated fair value of $74.05.

What do Wall Street analysts say about CL?

20 analysts cover Colgate-Palmolive Company with a consensus rating of "Buy." The average price target is $98.95, ranging from $87.00 to $110.00. This implies 13.7% upside from the current price.